TradingKey

關於 Pulmonx Corp 公司

Pulmonx Corporation 是一家商業階段的醫療技術公司。該公司爲患有嚴重肺氣腫（一種慢性阻塞性肺病）的患者提供微創治療。其解決方案由 Zephyr 支氣管內瓣膜（Zephyr 瓣膜）、Chartis 肺部評估系統（Chartis 系統）和 StratX 肺分析平臺（StratX 平臺）組成，旨在治療嚴重肺氣腫患者。StratX 平臺是一種基於雲的定量 CT 分析服務，可爲醫生提供針對其解決方案設計的報告，其中包括有關肺氣腫破壞、裂隙完整性和肺葉體積的信息，以幫助確定使用 Zephyr 瓣膜治療的目標肺葉。Chartis 系統是一種球囊導管和控制檯系統，帶有流量和壓力傳感器，旨在評估側支通氣的存在，並已在多項隨機對照臨牀試驗中得到驗證。

公司簡介

公司代碼LUNG

公司名稱Pulmonx Corp

上市日期Oct 01, 2020

CEOMr. Steven S. (Steve) Williamson

員工數量291

證券類型Ordinary Share

年結日Oct 01

公司地址700 Chesapeake Dr

城市REDWOOD CITY

上市交易所NASDAQ Global Select Consolidated

國家United States of America

郵編94063

電話16509342600

網址https://pulmonx.com/

公司代碼LUNG

上市日期Oct 01, 2020

CEOMr. Steven S. (Steve) Williamson

公司高階主管

名稱

名稱/職務

職務

持股

持股變動

Mr. Geoffrey Beran Rose

Chief Commercial Officer

237.06K

-2.85%

Mr. Daniel P. (Dan) Florin

Independent Director

102.02K

+145.58%

Mr. Richard M. (Rich) Ferrari

Independent Director

71.81K

+68.35%

Ms. Tiffany Sullivan

Independent Director

59.98K

+162.74%

Mr. Thomas William Burns

Independent Director

58.18K

+176.67%

Mr. Steven S. (Steve) Williamson

President, Chief Executive Officer, Director

30.45K

-24.58%

Mr. Mehul Joshi

Chief Financial Officer

11.52K

-41.16%

Mr. Brian Johnston

Investor Relations

--

Mr. David A. Lehman

General Counsel

--

Ms. Georgia Garinoismelenikiotou

Independent Director

--

名稱

名稱/職務

職務

持股

持股變動

Mr. Geoffrey Beran Rose

Chief Commercial Officer

237.06K

-2.85%

Mr. Daniel P. (Dan) Florin

Independent Director

102.02K

+145.58%

Mr. Richard M. (Rich) Ferrari

Independent Director

71.81K

+68.35%

Ms. Tiffany Sullivan

Independent Director

59.98K

+162.74%

Mr. Thomas William Burns

Independent Director

58.18K

+176.67%

Mr. Steven S. (Steve) Williamson

President, Chief Executive Officer, Director

30.45K

-24.58%

收入明細

單位: USD更新時間: 7月6日週日

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

暫無數據

地區USD

名稱

營收

佔比

United States

14.22M

63.10%

Europe, Middle-East and Africa ("EMEA")

5.48M

24.33%

Asia Pacific

2.79M

12.40%

Other International

38.00K

0.17%

業務

地區

暫無數據

股東統計

更新時間: 7月2日週三

持股股東

股東類型

持股股東

佔比

PRIMECAP Management Company

13.45%

Fidelity Management & Research Company LLC

11.71%

Morgan Stanley & Co. LLC

7.27%

BlackRock Institutional Trust Company, N.A.

6.30%

The Vanguard Group, Inc.

5.67%

Other

55.60%

持股股東

佔比

PRIMECAP Management Company

13.45%

Fidelity Management & Research Company LLC

11.71%

Morgan Stanley & Co. LLC

7.27%

BlackRock Institutional Trust Company, N.A.

6.30%

The Vanguard Group, Inc.

5.67%

Other

55.60%

股東類型

持股股東

佔比

Investment Advisor

51.20%

Hedge Fund

16.03%

Investment Advisor/Hedge Fund

14.74%

Research Firm

9.33%

Individual Investor

4.21%

Sovereign Wealth Fund

0.38%

Bank and Trust

0.19%

Pension Fund

0.05%

Insurance Company

0.03%

Other

3.85%

機構持股

更新時間: 7月1日週二

報告期間

機構數

持股數

持股佔比

持股變動

2025Q2

286

39.72M

98.66%

-2.86M

2025Q1

296

39.33M

97.70%

-4.34M

2024Q4

300

39.10M

98.27%

-6.73M

2024Q3

306

39.39M

100.59%

-8.60M

2024Q2

305

38.59M

99.39%

-11.14M

2024Q1

300

38.64M

99.54%

-10.45M

2023Q4

294

37.11M

96.84%

-10.90M

2023Q3

296

35.84M

94.15%

-16.29M

2023Q2

300

36.45M

96.58%

-16.49M

2023Q1

313

37.10M

98.35%

-13.03M

股東持股明細

名稱

持股數

佔比

持股變動

變動比例

公告日期

PRIMECAP Management Company

5.41M

13.45%

-97.53K

-1.77%

Mar 31, 2025

Fidelity Management & Research Company LLC

4.71M

11.71%

-443.86K

-8.61%

Mar 31, 2025

Morgan Stanley & Co. LLC

2.93M

7.27%

+396.76K

+15.68%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

2.54M

6.3%

-38.08K

-1.48%

Mar 31, 2025

The Vanguard Group, Inc.

2.28M

5.67%

-1.15K

-0.05%

Mar 31, 2025

Deerfield Management Company, L.P.

1.89M

4.69%

+355.24K

+23.15%

Mar 31, 2025

BNP Paribas Asset Management USA, Inc.

1.25M

3.11%

--

Mar 31, 2025

DWS Investments UK Limited

1.13M

2.81%

+31.06K

+2.82%

Mar 31, 2025

Silvercrest Asset Management Group LLC

930.56K

2.31%

+930.56K

--

Mar 31, 2025

Geode Capital Management, L.L.C.

927.54K

2.3%

+25.30K

+2.80%

Mar 31, 2025

持股ETF

更新時間: 8月2日週六

機構名稱

佔比

iShares Micro-Cap ETF

0.02%

iShares Russell 2000 Growth ETF

0.01%

Proshares Ultra Russell 2000

0%

Avantis US Equity ETF

0%

iShares Core S&P Total U.S. Stock Market ETF

0%

Global X Russell 2000 ETF

0%

Schwab U.S. Broad Market ETF

0%

FlexShares Morningstar US Market Factor Tilt Index Fund

0%

Goldman Sachs Innovate Equity ETF

0%

SPDR S&P Health Care Equipment ETF

0%

iShares Micro-Cap ETF

佔比0.02%

iShares Russell 2000 Growth ETF

佔比0.01%

Proshares Ultra Russell 2000

佔比0%

Avantis US Equity ETF

佔比0%

iShares Core S&P Total U.S. Stock Market ETF

佔比0%

Global X Russell 2000 ETF

佔比0%

Schwab U.S. Broad Market ETF

佔比0%

FlexShares Morningstar US Market Factor Tilt Index Fund

佔比0%

Goldman Sachs Innovate Equity ETF

佔比0%

SPDR S&P Health Care Equipment ETF

佔比0%

分紅派息

近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股

公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

Pulmonx Corp

1.695USD

Pulmonx Corp

1.695

概覽

公司

財務